WordNet

an antineoplastic drug often used to treat brain tumors or Hodgkins disease

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/10/09 16:19:09」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 再発高グレード神経膠腫のマネージメント management of recurrent high grade gliomas
2. 最新の診療アップデート practice changing updates
3. 未分化乏突起膠腫のマネージメント management of anaplastic oligodendroglial tumors
4. 髄芽腫の治療および予後 treatment and prognosis of medulloblastoma
5. 低悪性度神経膠腫のマネージメント management of low grade glioma

English Journal

Dithia[3.3]paracyclophane-bridged bimetallic ruthenium acetylide complexes: synthesis, structures and influence of transannular π-π interactions on their electronic properties.

Xia J, Ou YP, Wu D, Jin GJ, Yin J, Yu GA, Liu SH.SourceKey Laboratory of Pesticide & Chemical Biology, Ministry of Education College of Chemistry, Central China Normal University, 152 Luoyu Road, Wuhan, Hubei 430079, China. chshliu@mail.ccnu.edu.cn jianlongxia@gmail.com.
Dalton transactions (Cambridge, England : 2003).Dalton Trans.2013 Aug 14. [Epub ahead of print]
Two dithia[3.3]paracyclophane-bridged bimetallic ruthenium acetylide complexes and , in which the upper deck of the cyclophanes were assembled with naphthalenyl and anthracenyl rings, have been designed and synthesized. X-ray crystal structures of and show that there are effective transannular π-π
PMID 23945661

[4+3] Cycloaddition of in situ generated azoalkenes with C,N-cyclic azomethine imines: efficient synthesis of tetrazepine derivatives.

Hu XQ, Chen JR, Gao S, Feng B, Lu LQ, Xiao WJ.SourceKey Laboratory of Pesticide & Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, 152 Luoyu Road, Wuhan, Hubei 430079, China. jiarongchen2003@163.com wxiao@mail.ccnu.edu.cn.
Chemical communications (Cambridge, England).Chem Commun (Camb).2013 Aug 13;49(72):7905-7. doi: 10.1039/c3cc43888k. Epub 2013 Jul 30.
An unprecedented [4+3] cycloaddition of in situ generated azoalkenes with C,N-cyclic azomethine imines has been developed without the use of any catalyst, providing an efficient and mild approach to synthesise highly functionalized 1,2,4,5-tetrazepine derivatives in high yields (76-92%).
PMID 23900647

Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma.

Batchelor TT, Mulholland P, Neyns B, Nabors LB, Campone M, Wick A, Mason W, Mikkelsen T, Phuphanich S, Ashby LS, Degroot J, Gattamaneni R, Cher L, Rosenthal M, Payer F, Jürgensmeier JM, Jain RK, Sorensen AG, Xu J, Liu Q, van den Bent M.SourceTracy T. Batchelor, Rakesh K. Jain, and Gregory Sorensen, Massachusetts General Hospital, Boston, MA; Paul Mulholland, University College London, London; Rao Gattamaneni, the Christie Foundation Trust Hospital, Manchester, United Kingdom; Bart Neyns, Universitair Ziekenhuis Brussel, Brussels, Belgium; L. Burt Nabors, University of Alabama at Birmingham, Birmingham, AL; Mario Campone, Centre Rene Gauducheau, Saint-Herblain, France; Antje Wick, University of Heidelberg, Heidelberg, Germany; Warren Mason, Princess Margaret Hospital, Toronto, Ontario, Canada; Tom Mikkelsen, Henry Ford Hospital, Detroit, MI; Surasak Phuphanich, Cedars-Sinai Medical Center, Los Angeles, CA; Lynn S. Ashby, Barrow Neurological Institute, Phoenix, AZ; John DeGroot, MD Anderson Cancer Center, Houston, TX; Lawrence Cher, Austin Health Cancer Services; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Australia; Franz Payer, Medical University, Graz, Austria; Juliane M. Jürgensmeier, John Xu, and Qi Liu, AstraZeneca, Wilmington, DE; and Martin van den Bent, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.J Clin Oncol.2013 Aug 12. [Epub ahead of print]
PURPOSE: A randomized, phase III, placebo-controlled, partially blinded clinical trial (REGAL [Recentin in Glioblastoma Alone and With Lomustine]) was conducted to determine the efficacy of cediranib, an oral pan-vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor, either as
PMID 23940216

Japanese Journal

Least Squares Constant Modulus Blind Adaptive Beamforming with Sparse Constraint

LI Jun,XU Hongbo,XIA Hongxing,LIU Fan,LI Bo
IEICE transactions on communications 95(1), 313-316, 2012-01-01
NAID 10030537063

ロムスチン抵抗性の犬皮膚型リンパ腫に対して放射線治療を実施した1例

佐藤巌紀,西村麻紀,三好雅史,川本恵子,古林与志安,磯村洋,宮原和郎
日本獣医師会雑誌 = Journal of the Japan Veterinary Medical Association 63(9), 711-714, 2010-09-20
… 下唇の腫脹と下顎リンパ節の腫脹を伴った12歳のT細胞型皮膚型リンパ腫のシーズー犬に対してロムスチン（CCNU）による治療を行ったが効果は認められなかった。 …
NAID 10026611695